|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021311,
umls-concept:C0021832,
umls-concept:C0024530,
umls-concept:C0026538,
umls-concept:C0034961,
umls-concept:C0035647,
umls-concept:C0036323,
umls-concept:C0041703,
umls-concept:C0392756,
umls-concept:C0547047,
umls-concept:C0679199,
umls-concept:C0699788
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2000-4-26
|
|
pubmed:abstractText |
In 1997, enhanced health assessments were performed for 390 (10%) of approximately 4,000 Barawan refugees resettling to the United States. Of the refugees who received enhanced assessments, 26 (7%) had malaria parasitemia and 128 (38%) had intestinal parasites, while only 2 (2%) had Schistosoma haematobium eggs in the urine. Mass therapy for malaria (a single oral dose of 25 mg/kg of sulfadoxine-pyrimethamine) was given to all Barawan refugees 1-2 days before resettlement. Refugees >2 years of age and nonpregnant women received a single oral dose of 600 mg albendazole for intestinal parasite therapy. If mass therapy had not been provided, upon arrival in the United States an estimated 280 (7%) refugees would have had malaria infections and 1,500 (38%) would have had intestinal parasites. We conclude that enhanced health assessments provided rapid on-site assessment of parasite prevalence and helped decrease morbidity among Barawan refugees, as well as, the risk of imported infections.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-9637
|
|
pubmed:author |
pubmed-author:AddissD GDG,
pubmed-author:CHAON TNT,
pubmed-author:CetronM SMS,
pubmed-author:CooksonS TST,
pubmed-author:GonzagaP SPS,
pubmed-author:GushulakB DBD,
pubmed-author:MillerJ MJM,
pubmed-author:Nguyen-DinhPP,
pubmed-author:OstrowskiS RSR,
pubmed-author:PariseM EME,
pubmed-author:WahlquistS PSP,
pubmed-author:WainwrightR BRB,
pubmed-author:WeldL HLH,
pubmed-author:WilsonMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
115-21
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10761735-Adolescent,
pubmed-meshheading:10761735-Adult,
pubmed-meshheading:10761735-Aged,
pubmed-meshheading:10761735-Animals,
pubmed-meshheading:10761735-Antimalarials,
pubmed-meshheading:10761735-Child,
pubmed-meshheading:10761735-Child, Preschool,
pubmed-meshheading:10761735-Coccidiosis,
pubmed-meshheading:10761735-Cryptosporidiosis,
pubmed-meshheading:10761735-Cryptosporidium parvum,
pubmed-meshheading:10761735-Drug Combinations,
pubmed-meshheading:10761735-Eucoccidiida,
pubmed-meshheading:10761735-Female,
pubmed-meshheading:10761735-Humans,
pubmed-meshheading:10761735-Infant,
pubmed-meshheading:10761735-Intestinal Diseases, Parasitic,
pubmed-meshheading:10761735-Malaria, Falciparum,
pubmed-meshheading:10761735-Male,
pubmed-meshheading:10761735-Mass Screening,
pubmed-meshheading:10761735-Middle Aged,
pubmed-meshheading:10761735-Plasmodium falciparum,
pubmed-meshheading:10761735-Pyrimethamine,
pubmed-meshheading:10761735-Refugees,
pubmed-meshheading:10761735-Schistosomiasis haematobia,
pubmed-meshheading:10761735-Schistosomiasis mansoni,
pubmed-meshheading:10761735-Somalia,
pubmed-meshheading:10761735-Sulfadoxine,
pubmed-meshheading:10761735-United States
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections.
|
|
pubmed:affiliation |
Division of Quarantine, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
|
|
pubmed:publicationType |
Journal Article
|
